Research library

Global Cannabis Applications Corp.

OTC: FUAPF, CSE: APPCannabis technology

Designs, develops, licenses and acquires data technologies for the medical cannabis industry. Its Citizen Green and Efixii platforms are end to end medical cannabis data solutions, from patient to regulator.

Updated Corporate ProfileReport
June 7, 2021Date
10 pagesLength
Page one of the Global Cannabis Applications Corp. updated corporate profile
Global Cannabis Applications Corp. logo

Report details

Company
Global Cannabis Applications Corp.
Listing
OTC: FUAPF, CSE: APP
Industry
Cannabis technology
Report
Updated Corporate Profile
Date
June 7, 2021
Length
10 pages

Global Cannabis Applications Corp. (GCAC), headquartered in Vancouver, Canada, with a satellite office in Israel, provides proprietary data technologies and applications for the global medical cannabis industry. Organized in July 2014 and formerly known as Fundamental Applications Corp., it focused after a name change in April 2017 on its Citizen Green software suite, designed to improve cannabis patient outcomes by addressing product quality and compliance challenges in different regulatory environments.

Its Seed2Seed system, for which a U.S. patent was filed in December 2019, combines consumer efficacy feedback with batch-specific product life-cycle data. Using artificial intelligence, blockchain attestation software and machine learning, the Citizen Green platform and its mobile Efixii app create chain-of-custody records from mother plant seed to retail shelf, linking growers, manufacturers, labs, distributors, retailers, patients, health care practitioners and regulators. Having launched the full solution in October 2020, GCAC secured license agreements with clients in Israel, Romania and Malta and received its first revenue payment in March 2021.

OTC: FUAPF, CSE: APP · Cannabis technology

Read the updated corporate profile (PDF, 10 pages)

Company website: cannappscorp.com

WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. This page is for information only and is not an offer or solicitation to buy or sell any security. Read the Disclaimer

All research reports